These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10737737)

  • 21. Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
    Sugimoto T; Tanikawa T; Suzuki K; Yamasaki Y
    Bioorg Med Chem; 2012 Oct; 20(19):5787-801. PubMed ID: 22925450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
    Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
    Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs.
    Kashimura M; Asaka T; Misawa Y; Matsumoto K; Morimoto S
    J Antibiot (Tokyo); 2001 Aug; 54(8):664-78. PubMed ID: 11592503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
    Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
    Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antibacterial activity of C12 des-methyl ketolides.
    Lin X; Rico AC; Chu DT; Carroll GL; Barker L; Shawar R; Desai MC; Plattner JJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4692-6. PubMed ID: 16784845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.
    Wootton M; Bowker KE; Janowska A; Holt HA; MacGowan AP
    J Antimicrob Chemother; 1999 Oct; 44(4):445-53. PubMed ID: 10588304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides.
    Hu L; Lan P; Song QL; Huang ZJ; Sun PH; Zhuo C; Wang Y; Xiao S; Chen WM
    Eur J Med Chem; 2010 Dec; 45(12):5943-9. PubMed ID: 20970894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
    Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides.
    Abbanat D; Webb G; Foleno B; Li Y; Macielag M; Montenegro D; Wira E; Bush K
    Antimicrob Agents Chemother; 2005 Jan; 49(1):309-15. PubMed ID: 15616310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
    Reinert RR; Rodloff AC; Halle E; Baer W; Beyreiss B; Seifert H; Wichelhaus TA; Maass M; Mehl M
    Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M; Farrell DJ; Kaneko K; Akizawa K; Fujita S; Kaku M; Igari J; Yamaguchi K; Yamanaka K; Murase M; Asari S; Hirakata Y; Baba H; Itaha H
    Microb Drug Resist; 2008 Jun; 14(2):109-17. PubMed ID: 18500920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.